# OnCo record biocon-biologics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/biocon-biologics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "biocon-biologics" ;
  schema:name "Biocon Biologics"@en ;
  schema:description "Biocon's biosimilars arm, one of the few companies outside the US and Europe with FDA- and EMA-approved cancer antibody biosimilars, and since 2022 the owner of Viatris's biosimilars business."@en ;
  schema:url <https://onco.cc/companies/biocon-biologics/>, <https://www.bioconbiologics.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.bioconbiologics.com>, <https://www.ema.europa.eu/en/medicines/human/EPAR/ogivri>, <https://www.ema.europa.eu/en/medicines/human/EPAR/abevmy> ;
  schema:addressCountry "IN" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-biosimilars/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/bevacizumab/> ;
  onco:companies <https://onco.cc/companies/biocon/> ;
  onco:terms <https://onco.cc/terms/biosimilar/> ;
  onco:people <https://onco.cc/people/mazumdar-shaw-kiran/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-global-access/> .